Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-540

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 68001-540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Bortezomib 01)

Chemical Structure (Bortezomib 01)
FDA Label Image

Figure 1 (Bortezomib 02)

Figure 1 (Bortezomib 02)
FDA Label Image

Figure 2 (Bortezomib 03)

Figure 2 (Bortezomib 03)
Not-Available. The text seems to be random characters and numbers that do not form a coherent description.*
FDA Label Image

Figure 3 (Bortezomib 04)

Figure 3 (Bortezomib 04)
FDA Label Image

Figure 4 (Bortezomib 05)

Figure 4 (Bortezomib 05)
This text seems to be showing the results of a study involving the use of Bortezomib and Dexamethasone in patients. It includes some numeric values and a p-value from a log-rank test. However, without additional context, it is difficult to determine the purpose of the study or the significance of the results.*
FDA Label Image

Figure 5 (Bortezomib 06)

Figure 5 (Bortezomib 06)
FDA Label Image

Figure 6 (Bortezomib 07)

Figure 6 (Bortezomib 07)
FDA Label Image

Vial Label (Bortezomib 08)

Vial Label (Bortezomib 08)
This is the packaging information for Bortezomib, a cytotoxic injection for intravenous or subcutaneous use. It contains 3.5 mg of Bortezomib and 35 mg of mannitol. The instructions advise to discard any unused portion and store at no more than 25°C, protecting it from light. It also includes standard safety warnings and dosage instructions. The product is manufactured by Bliss Paint Laboratories in China.*
FDA Label Image

Carton Label (Bortezomib 09)

Carton Label (Bortezomib 09)
FDA Label Image

Inside Flap (Bortezomib 10)

Inside Flap (Bortezomib 10)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.